Skip to main content

Posts

Showing posts from February, 2020

Animal Drug Compounding Market Detailed Analytical Overview By 2019 to 2029

Persistence Market Research published a report on the animal drug compounding market, which considers the U.S. industry analysis 2014 – 2018 and opportunity assessment 2019 – 2029, and projects that the  animal drug compounding market  is expected to reach ~  US$ 1 Bn  by the end of 2019 in terms of value, and is forecasted to reach ~  US$ 2 Bn  by the end of 2029. Availability of Alternative Dosage Forms Boosting the Demand for Animal Drug Compounding Commercially available veterinary drugs often come in a single dosage or strength. Animal drug compounding is able to produce desired drugs with alternate dosage and varied dosage forms, which is not possible during the production of branded drugs. Such types of animal drug compounding involve concentrating the drug in the flavoured gel that is generally applied to the paw or fur of the animal, and is administered by licking. Also, dosage forms such as transdermal drug delivery in animals, are widel...

Mitotane Market Is Expected To Grow At A CAGR 5% By The End Of 2029

Over the years, mitotane has become one the preferred choices of treatment for Cushing’s syndrome and ACC. The growth of the  mitotane market  can be attributed to the increased incidence of patient population, which is anticipated to grow significantly in the forecast period. Furthermore, late recurrence of Cushing’s syndrome and late diagnosis and detection also favours the growth of the mitotane market.  ACC has been marked with a high recurrence rate, where treatment using adjuvant therapy has been found to be extremely successful. The  ~US$ 12 billion  market for mitotane is anticipated to grow at a healthy CAGR over the period of next decade. Macro-economic factors, such increase expenditure in healthcare sector in emerging nations such as  China, India, and Brazil  is expected to boost the growth of the mitotane market in the forecast period. With the rise and continual growth in global healthcare expenditure, sales of pharma drugs such ...

Shrimp Disease Diagnostics Market Accounting For US$ XX Mn By 2029

The   shrimp disease diagnostics market   has been analyzed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA and Emerging Countries such as China, Thailand and India.  Due to the high viral-borne endemic shrimp diseases, countries such as China, Thailand, and India are estimated to be the fastest-growing regional markets for shrimp disease diagnosis, and are poised to offer significant opportunities. With a large number of ongoing research initiatives pertaining to shrimp disease, the demand for shrimp disease diagnostics is estimated to grow significantly over the forecast period. Moreover, mergers & acquisitions and research-based collaboration agreements by key manufacturers in the shrimp disease diagnostics market are also among factors estimated to fuel the growth of the market. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/sampl...

Kidney Dialysis Equipment Market Is Expected To Grow At A CAGR 6.5% By The End Of 2024

Persistence Market Research’s recent report on  “ Global Market Study on  Kidney Dialysis Equipment: Latin America Expected  to Emerge the Third Attractive Regional Market ” forecasts the market revenues to reach  US$ 25.128 Bn  by 2024 end. The  US$ 15 Bn   kidney dialysis market  is projected to grow at a  CAGR of 6.5%  through 2024. Increasing Prevalence of Chronic Kidney Disease and Adoption of Technologically Advanced Products Spurring Demand The preponderance of chronic kidney disease (CKD), aggravated by geriatric population and rising life expectancy, will continue to spur the demand for hemodialysis therapy. Expanding ESRD patient pool is another factor influencing market growth. Favorable government initiatives and rising healthcare funding to increase awareness about therapeutic modalities are also anticipated to boost equipment sales during the forecast period. The introduction of technologically advanced an...

Precision Medicine Market To Exceed US$ 34 Mn By 2024

The latest report published by Persistence Market Research titled “ Global Market Study on Precision Medicine: Drug Discovery Technology  Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global  precision medicine market  after an in-depth research. The report assures that the market will grow manifold and it will register a  14.7% CAGR between 2016 and 2024. Global Precision Medicine Market: The Propellers The global expansion of the medicine industry will expand the canvas of the global precision market. Larger investments, better infrastructure, simplified approval process of drugs along with companion diagnostics will impact the structure of the entire climate of the global precision medicine market. The affordable DNA profiling, the bloating cancer population of the globe will create a favorable condition of growth for the global precision medicine market. The proper storage of ...

Eustachian Tube Dysfunction Treatment Market To Hold A High Potential For Growth By 2019 - 2029

Illness such as common cold and allergies are the main reasons of Eustachian tube dysfunction which causes the Eustachian tube to become inflamed or clogged with the mucus. Eustachian tube dysfunction is generally used to patient with sinus infections. Wide options are available for the treatment of eustachian tube dysfunction such as over the counter and prescribed drugs. New development in the management of eustachian tube is expected to create huge potential for the eustachian tube dysfunction treatment market to grow in the forecast period. Eustachian tube dysfunction is estimated to occur as chronic condition in the adults worldwide which further drive the eustachian tube dysfunction market in the near future. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/29497 Growing research on the surgical procedure and growing treatment option is expected to spur the eustachian tube dysfunction market. A...

Latex Agglutination Test Market Prophesied To Grow At A Faster Pace By 2019 - 2029

Moreover, the latex agglutination assay gives rapid advantage for quick results within a shorter period of time. Additionally, latex agglutination test provides the versatility of the reaction, simple design and ability to work in small quantity of the sample. Among the multiple diseases, the test mostly used for the serological diagnosis of rheumatoid arthritis. However, the latex agglutination principle also used in the diagnosis of infections like Hepatitis B, H.influenzae, N. meningitidis, etc. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/29470 Latex agglutination test market anticipated growth in the forecast period with rising patent pool suffering from rheumatoid arthritis, anticipated to grow over the forecast period. The effectiveness of the testing outcome is the major driver for the latex agglutination test market. However, the latex agglutination test also applied to the diagnosis...

Hormone Biosimilars Market To Hold A High Potential For Growth By 2019 - 2029

The incidence of the growth hormone deficiency is reported to be around 1 in 7,000 in the U.S. The diagnosis plays major role in the management of growth hormone deficiency. Children with cleft palates are often result of growth hormone deficiency. The growth hormone deficiency may result in various deformities ranging from non-proportionate body organs to abnormal body functioning. Various psychological symptoms may occur such as depression, lack of concentration, poor memory and anxiety, etc. in patient with growth hormone deficiency. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/29467 Increasing early diagnosis of the growth hormone related disorder is the major driver in the growth of the growth hormone biosimilars market. The evolving methods of diagnosis of the growth hormone deficiency further expected to boost the diagnosis rate, driving the growth of growth hormone biosimilars market. ...

Autoimmune Hepatitis Therapeutics Market Detailed Analytical Overview By 2019 - 2029

There are primarily two types of autoimmune hepatitis that include, Type 1 and Type 2. Type 1 autoimmune hepatitis is the most common type and can occur at any age. About 50% of patients that are diagnosed with autoimmune hepatitis have underlying autoimmune conditions that trigger it. The type 2 autoimmune hepatitis is common in children and young adults. Some of the complications associated with such conditions include, enlarged veins in the esophagus, accumulation of fluid in the abdomen, liver failure, and liver cancer. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/29464 Typically, the treatment for autoimmune hepatitis start with high dose of corticosteroids that is gradually decreased to determine the lowest dosage that is suitable for the patient. Nearly 80% of patients experience that the disease is controlled after usage of autoimmune hepatitis therapeutics for 3 years. Most patients ...

Antiplatelet Therapy Market To Hold A High Potential For Growth By 2019 - 2029

Antiplatelet therapy is required in procedures of artificial heart valves and stents placements, coronary artery bypass procedure and angioplasty. These factors contribute to heart conditions. Antiplatelet therapy market is expanding due to its increasing usage in artificial heart valve placements, coronary artery bypass surgeries, angioplasty etc. The death rate in the United States due to heart conditions is 630,000 each year. They contribute $200 billion to their health care expenditures caused specifically due to heart diseases. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here  @  https://www.persistencemarketresearch.com/samples/29458 The estimate increase in mortality rate due to cardiac failures will be 22 million by 2030. Antiplatelet therapy Market is directly proportional to cardiac surgeries. The Antiplatelet therapy market is anticipated to increase due to increasing cardiac disorders. Antiplatelet therapy market: drivers and res...

Absorbable Punctum Plugs Market Prevalent Opportunities Up To 2019 - 2029

Absorbable punctum plugs are also referred as tear lacrimal plug or punctal occluders. Absorbable punctum plugs majorly used for the treatment of dry eye.  Absorbable punctum plugs is a tiny device which is inserted into the teat duct of an eye. The insertion of Absorbable punctum plugs in the tear duct, blocks the opening of duct which prevents the drainage of liquid from eye. This ultimately increases eye’s tear films which mist the surface of the eye to relieve the dry eyes. Absorbable punctum plugs are widely accepted device for the treatment of dry eyes though it is safe, painless, quick and completely reversible. Absorbable punctum plugs are temporary plugs which are initially recommended by the doctor to observe, how a patient with dry eye react to this treatment method. Absorbable punctum plugs are made up of collagen material, hence it dissolves naturally in the human body. If a patient body reacts well for absorbable punctum plugs then the doctor may prescribe t...

Glycobiology Market Is Estimated To Translate To A Revenue Of US$ 1,670.3 Mn By 2024 According To Market Forecast

Extensive research related to carbohydrate molecule in various fields such as marine science and food & beverages industry is expected to fuel growth of the global  glycobiology market . The global market is expected to reach a value of  US$ 1,670.3 Mn by 2024 , registering a  CAGR of 12.8% between 2016 and 2024 , according to a new report by Persistence Market Research (PMR). PMR’s report offers market forecast and analysis on the  global glycobiology market , while segmenting the market on the basis of product-type, application, end-user, and region. The report segments the global glycobiology market into five key regions: North America, Latin America, Europe, Middle East and Africa (MEA), and Asia Pacific (APAC).  According to PMR regional analysis, North America (including the U.S. and Canada) is the most lucrative market for glycobiology globally. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistence...